Qiming granule in treating type 2 diabetic kidney disease patients: study protocol for a randomized controlled trial
Journal Title: Traditional Medicine Research - Year 2021, Vol 6, Issue 1
Abstract
Background: Diabetic kidney disease (DKD) is a chronic renal microvascular complication associated with abnormal glucose metabolism. According to traditional Chinese medicine (TCM) theory, Qi and Yin deficiency with blood stasis (the name of TCM symptoms, its main clinical features are fatigue, dry mouth, red or pale tongue, weak pulse, etc.) is the primary TCM syndrome of DKD, and Qiming granule (QMG) is suitable for the treatment of Qi and Yin deficiency with blood stasis syndrome. In view of this, we designed a randomized controlled trial to assess whether QMG is efficacious and safe in treating DKD patients. Methods: This protocol is for a randomized, double-blind, placebo-controlled, parallel group, six-centre clinical trial. A total of 180 participants will be randomized into the QMG group or placebo group, with a 1:1 ratio. The study will last for 50 weeks, including a 2-week run-in period, 24 weeks of intervention, and 24 weeks of follow-up. The experimental intervention will be QMG, and the control intervention will be a placebo. The primary outcome will be the 24h urinary albumin excretion ratio and the change in the albumin-to-creatinine ratio. The secondary outcome will be evaluation of renal function, fundus changes, management of blood lipids, TCM symptom improvement and safety assessments. Adverse events will be recorded during the trial. Discussion: This study is a randomized controlled trial to test the effectiveness and safety of QMG for DKD patients. The findings of this study will help to provide evidence-based recommendations in treating DKD patients. Trial registration: Chinese Clinical Trial Registry, ChiCTR-TRC-12002953. Registered 23 December 2012.
Authors and Affiliations
Jian Huo,Jun-Guo Duan,Xue-Jing Lu,Fu-Wen Zhang,Wen-Yuan Jian, Jia-Qing Sui,Jia-Ling Ai,Li-Sha Liu
Keywords
Related Articles
- EP ID EP690506
- DOI 10.12032/TMR20200105149
- Views 153
- Downloads 0
Jian-Gan-Xiao-Zhi decoction ameliorates high-fat high-carbohydrate diet-induced non-alcoholic fatty liver disease and insulin resistance by regulating the AMPK/JNK pathway
Background: Non-alcoholic fatty liver disease (NAFLD) can cause insulin resistance (IR) and diabetes. Our previous studies have demonstrated that Jian-Gan-Xiao-Zhi decoction (JGXZ) could be effective for the treatment of...
Is Colla Corii Asini just boiled donkey skin?
The preparation of Chinese medicine, exploration of the bioactive component, and underlying mechanism of traditional Chinese medicine (TCM) have always been regarded as a research hotspot and have attracted increasing at...
Research hotspot and frontier progress of cancer under the background of precision medicine
The timely introduction and rapid development of precision medicine have provided strong theoretical support and technical support for tumor research. The treatment methods have been developed from single to multiple; th...
Research progress in the use of leeches for medical purposes
Leeches are invertebrates that have a long history of application in the development of human medicine in both the East and the West. This paper comprehensively analyzes and evaluates current research and the latest prog...
Acupuncture preconditioning protects against myocardial ischemia/reperfusion injury mediated apoptosis through miR-214/NCX1 activation: a hypothesis
Early reperfusion of ischemic cardiac tissue is usually the best option to improve clinical outcome of angina pectoris, especially of acute myocardial infarction. However, myocardial reperfusion may cause an abnormal inc...